Expression Table for this CRE
| CNhs13844 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2 | 3.1 |
| CNhs13839 | iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2 | 2.4 |
| CNhs13837 | iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1 | 2.2 |
| CNhs13845 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2 | 2.2 |
| SRX9760345 | skeletal muscle_1_h_after_exercise (Individual 6) | 1.8 |
| SRX9760361 | skeletal muscle_2_min_after_exercise (Individual 3) | 1.5 |
| CNhs14077 | spinal cord, newborn, donor10223 | 1.3 |
| CNhs13836 | iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1 | 1.1 |
| CNhs13840 | iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2 | 1.0 |
| SRX9760352 | skeletal muscle_1_h_after_exercise (Individual 1) | 0.9 |
| CNhs13833 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1 | 0.9 |
| SRX9760353 | skeletal muscle_3_h_after_exercise (Individual 1) | 0.9 |
| CNhs13345 | Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19) | 0.8 |
| LShi10030_ACAGTG-CACTATG | Human induced pluripotent stem cells grown on feeder-free condition, biol_rep3 | 0.8 |
| CNhs11991 | Smooth Muscle Cells - Umbilical Artery, donor2 | 0.7 |
| SRX9760346 | skeletal muscle_3_h_after_exercise (Individual 6) | 0.7 |
| SRX9760360 | skeletal muscle_prior_exercise (Individual 3) | 0.7 |
| CNhs12655 | MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2 | 0.7 |
| CNhs14501 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2 | 0.6 |
| CNhs14499 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3 | 0.6 |
| CNhs12662 | MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2 | 0.6 |
| CNhs14495 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2 | 0.6 |
| CNhs12950 | H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41) | 0.6 |
| CNhs14541 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1 | 0.5 |
| CNhs12101 | Mesenchymal Stem Cells - adipose, donor2 | 0.5 |
| CNhs13338 | mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1 | 0.5 |
| CNhs13581 | Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45) | 0.5 |
| CNhs12653 | MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2 | 0.5 |
| CNhs12667 | MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2 | 0.5 |
| CNhs14485 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1 | 0.4 |
| SRX9760336 | skeletal muscle_3_h_after_exercise (Individual 4) | 0.4 |
| CNhs12684 | K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2 | 0.4 |
| CNhs13434 | mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1 | 0.4 |
| CNhs13110 | Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12) | 0.4 |
| CNhs12663 | MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2 | 0.4 |
| CNhs13577 | Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33) | 0.4 |
| SRX9760356 | skeletal muscle_2_min_after_exercise (Individual 2) | 0.4 |
| CNhi10789_ATG | Human primary dermal fibroblasts derived from neonatal foreskin, biol_rep3 | 0.4 |
| CNhs12654 | MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2 | 0.4 |
| SRX9760364 | skeletal muscle_6_h_after_exercise (Individual 3) | 0.3 |
| CNhs11776 | skeletal muscle, fetal, donor1 | 0.3 |
| CNhs12666 | MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2 | 0.3 |
| SRX6586373 | CNhi10370_MCF-7_siRNA (HSS179267) treatment-48h_rep1 | 0.3 |
| CNhs12332 | B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2 | 0.3 |
| CNhs11725 | argyrophil small cell carcinoma cell line:TC-YIK | 0.3 |
| CNhs12801 | K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3 | 0.3 |
| CNhs11884 | teratocarcinoma cell line:NCR-G1 | 0.3 |
| CNhs11903 | Gingival epithelial cells, donor3 (GEA15) | 0.3 |
| CNhs12117 | Astrocyte - cerebellum, donor3 | 0.3 |
| CNhs13545 | CD14+ monocytes - treated with lipopolysaccharide, donor3 | 0.3 |